How cool is this? Neuralink’s Blindsight implant could give blind volunteers basic vision by late 2025
Instead of fixing eyes, it sends signals straight to the brain’s visual cortex through a flexible mesh of hair-thin electrodes.
Imagine a tablet-sized implant under your skull, connected by threads thinner than a human hair. Each thread carries electrical pulses that light up specific spots in your visual cortex, creating patterns you can learn to recognise. Early tests in animals already show simple shapes and light patterns—and now humans will get their turn.
Neuralink opened a global registry to find volunteers born blind or who lost sight later. The trial will first check safety—looking at infection risk, tissue response and device stability. Then comes the fun part: can participants tell circles from squares? Even low-resolution vision would transform daily life.
The FDA gave Blindsight “breakthrough device” status in September 2024, which fast-tracks discussions without skipping safety checks. Neuralink may work with clinics in the UAE, tapping surgical expertise and diverse volunteers.
On the tech side, its adaptive algorithms will decode each person’s unique brain signals. As volunteers train, their brains will learn to interpret these new inputs. Rehabilitation specialists will guide them through each step, helping turn electric pulses into real-world sight.
This isn’t a sci-fi movie—it’s real, happening now. Blindsight could expand treatment to millions with untreatable vision loss. In a few months, humans will test direct brain stimulation for sight. How often do you get to watch history unfold?
Neuralink’s Blindsight trial shows what’s possible when engineers, clinicians and regulators unite around one goal: restoring vision in a brand-new way. Keep an eye on the headlines—this is one story you’ll want to follow.
